Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B Virus-Related Hepatocellular Carcinoma”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Not applicableStudy completedNCT05406089
What this trial is testing

Effects of Antiviral Therapy on Patients With HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaHepatitis B VirusSurvival
First Affiliated Hospital Xi'an Jiaotong University 494
Post-approval studies (Phase 4)Study completedNCT07084948
What this trial is testing

Inhibition of HBV Replication and Biological Reversal of Cirrhosis (F3-F4) and HCC by Flavonoids

Who this might be right for
Hepatitis B Virus Infection
Trieu, Nguyen Thi, M.D. 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT03419481
What this trial is testing

Pembrolizumab in Hepatocellular Carcinoma

Who this might be right for
HCC
CCTU 30
Testing effectiveness (Phase 2)UnknownNCT04317248
What this trial is testing

"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Yuehua Huang 600
Not applicableNot Yet RecruitingNCT07120750
What this trial is testing

Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Chronic Hepatitis B
Shenzhen Third People's Hospital 332
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05195294
What this trial is testing

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, AdultLiver Cell Carcinoma
Lion TCR Pte. Ltd. 55
Not applicableStudy completedNCT04415567
What this trial is testing

Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Jinyang Gu 23
Not applicableUnknownNCT01957618
What this trial is testing

The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy

Who this might be right for
Hepatitis B Virus-Related Hepatocellular Carcinoma
National Taiwan University Hospital 1,500
Early research (Phase 1)Study completedNCT02686372
What this trial is testing

TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 13
Early research (Phase 1)Looking for participantsNCT04745403
What this trial is testing

Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)

Who this might be right for
Hepatocellular Carcinoma
Lion TCR Pte. Ltd. 10
Not applicableStudy completedNCT00629486
What this trial is testing

Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma

Who this might be right for
Hepatitis BHepatocellular CarcinomaChronic Liver Disease
Kaohsiung Medical University Chung-Ho Memorial Hospital 300
Not applicableUnknownNCT05256459
What this trial is testing

Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma

Who this might be right for
Time
Zhang Dazhi,MD 1,000
Not applicableUnknownNCT03020342
What this trial is testing

HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC

Who this might be right for
Carcinoma, Hepatocellular
National Taiwan University Hospital 50
Not applicableStudy completedNCT00824707
What this trial is testing

Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
Eastern Hepatobiliary Surgery Hospital 200
Not applicableNot Yet RecruitingNCT07253220
What this trial is testing

TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma

Who this might be right for
Hepatitis BHepatocellular Carcinoma (HCC)
Sun Yat-sen University 120
Not applicableNot Yet RecruitingNCT07544121
What this trial is testing

Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis

Who this might be right for
HEPATITIS B CHRONICCirrhosis, LiverHepatocellular Carcinoma (HCC)
Nanfang Hospital, Southern Medical University 1,034
Not applicableLooking for participantsNCT05466565
What this trial is testing

Antiviral Therapy for Patients With Liver Cancer After Surgery

Who this might be right for
Hepatocellular Carcinoma
Xiangya Hospital of Central South University 360
Not applicableNot Yet RecruitingNCT05752890
What this trial is testing

A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatitis b VirusRadiotherapy+1 more
National Taiwan University Hospital 95
Not applicableLooking for participantsNCT07769827
What this trial is testing

Peg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCC

Who this might be right for
HBV-HCCUnresectable Advanced HBV-related Liver Cancer
Jinling Hospital, China 33
Post-approval studies (Phase 4)UnknownNCT02281266
What this trial is testing

Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection

Who this might be right for
Curable Hepatitis B Virus-Related Hepatocellular Carcinoma
Jia Fan 360
Next Page